Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Century Pharmaceuticals is an Indianapolis-based specialty pharmaceutical company that focuses on the development and manufacturing of topical anti-infective solutions for wound care. Founded in 1966, the company is best known for its stabilized Dakin's Solution products, including the flagship Di-Dak-Sol brand, which contains 0.0125% sodium hypochlorite. These solutions are specifically formulated to be shelf-stable and non-irritating, making them ideal for treating chronic wounds, pressure sores, and diabetic ulcers without damaging healthy tissue. Century Pharmaceuticals operates a cGMP-compliant manufacturing facility and serves a wide range of healthcare providers, including hospitals, wound care centers, and home health agencies. The company's commitment to quality and standardization has made its products a staple in clinical wound management for over five decades.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Di-Dak-Sol.